Who Owns Band-Aid?
Band-Aid is owned by Kenvue Inc. (NYSE: KVUE), a publicly traded American consumer health company headquartered in Skillman, New Jersey. Kenvue was spun off from Johnson & Johnson in May 2023 and holds the Band-Aid brand as part of its Self Care segment. Band-Aid was invented in 1921 by Earle Dickson, a Johnson & Johnson employee. Kimberly-Clark Corporation announced an agreement to acquire Kenvue for approximately $48.7 billion in November 2025; shareholders of both companies voted to approve the deal on April 29, 2026, with closing expected in the second half of 2026.
Parent Company
Kenvue
Founded
1921
Status
Publicly Traded
Headquarters
Skillman, New Jersey, United States
Who Owns Band-Aid?
- Parent Company: Kenvue
- Ownership Type: Brand division
- Company Type: Publicly Traded
- Stock Ticker: NYSE: KVUE
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Band-Aid | Kenvue | Brand division |
History of Band-Aid
- Founded: 1921
- Founders: Earle Dickson
Band-Aid was invented in 1921 by Earle Dickson, a cotton buyer employed at Johnson & Johnson in New Brunswick, New Jersey. Dickson's wife, Josephine, frequently cut and burned herself while cooking. Dickson solved the problem by layering gauze pads on strips of adhesive tape and covering them with crinoline fabric so they could be unrolled and cut to size. When he showed the concept to his supervisor at Johnson & Johnson, the company recognized its commercial potential.
Johnson & Johnson began manufacturing Band-Aid adhesive bandages commercially in 1921. Early production was done by hand and sales were modest. The company distributed Band-Aid products free to Boy Scout troops as a promotional strategy, which helped build early brand recognition. By 1924, machine-manufactured Band-Aid strips were in production, which reduced cost and allowed broader retail distribution.
Throughout the 1930s and 1940s, the brand expanded its product range. Decorated bandages were introduced in 1956, initially for children. The decorated designs, later including licensed characters, became a durable product category that remains active today.
Johnson & Johnson trademarked the name "Band-Aid" in 1921. The brand became so dominant in its category that "Band-Aid" entered popular use as a generic term for adhesive bandages in the United States, though Johnson & Johnson has consistently defended the trademark. The brand became a component of Johnson & Johnson's consumer health division, which operated for decades under the Johnson's, Neutrogena, Tylenol, Listerine, and Band-Aid brand umbrella.
In 2023, Johnson & Johnson completed the separation of its consumer health business into Kenvue Inc., transferring Band-Aid along with the full consumer health brand portfolio. Band-Aid has been sold in more than 100 countries and is available across grocery, pharmacy, mass retail, and e-commerce channels globally.
About Kenvue
Kenvue is an American consumer health company founded in 2023 through a spin-off from Johnson & Johnson, headquartered in Jersey City, New Jersey. Under CEO Kirk Perry, Kenvue trades on NYSE (KVUE) and is the world's largest pure-play consumer health company by revenue. The company specializes in over-the-counter health and wellness products with iconic brands including Tylenol, Listerine, Band-Aid, and Neutrogena, reporting Q3 2025 net sales decline of 3.5% with adjusted diluted EPS of $0.28.
- Founded: 2023
- Headquarters: Jersey City, New Jersey, USA
- Company Type: Publicly Traded
- Stock: NYSE: KVUE
- Revenue: approximately $14.9 billion (FY2024)
- Employees: Approximately 22,000
Where Is Band-Aid Made / Based?
- Headquarters: Skillman, New Jersey, United States
- Manufacturing / Operations: United States, Canada, Mexico, Belgium, Brazil
Band-Aid Sustainability & Ethics
Band-Aid operates within Kenvue's corporate sustainability framework. Kenvue has published Environmental, Social, and Governance (ESG) commitments including targets for reducing greenhouse gas emissions, increasing the use of recycled packaging materials, and responsible ingredient sourcing.
Kenvue has committed to making all primary packaging recyclable, reusable, or refillable by 2025 where infrastructure allows. Band-Aid's packaging has been updated progressively to increase recycled content and reduce unnecessary plastic.
Band-Aid adhesive bandages are classified by the FDA as Class I medical devices. This classification means they are subject to FDA's general controls, including proper labeling, good manufacturing practice requirements, and adverse event reporting. Kenvue files product registrations and facility registrations with FDA for Band-Aid manufacturing locations.
No independent third-party sustainability certifications specific to Band-Aid products (such as FSC, Rainforest Alliance, or Leaping Bunny) are listed in those organizations' public databases as of July 2026.
Awards & Recognition
Band-Aid's most verifiable recognition is its market position as the dominant brand in U.S. adhesive bandage retail sales, a position it has held since the mid-20th century. The brand has been cited in Kantar's Brand Footprint survey and similar brand tracking studies as one of the most purchased consumer health brands in the United States.
Johnson & Johnson, as Band-Aid's prior parent company, was listed on the Dow Jones Sustainability Index for multiple years prior to the Kenvue separation. Kenvue, as the current parent, began publishing its own ESG disclosures following the 2023 IPO.
No independently verified industry awards specific to Band-Aid products are documented in verifiable award databases as of July 2026.
Band-Aid Recalls & Controversies
2024 and 2025 Product Recalls: In August 2024, Kenvue issued a voluntary recall of certain Band-Aid Flexible Fabric adhesive bandages due to potential contamination with small metal particles. The recall affected specific lot numbers manufactured at a third-party supplier. The FDA classified the recall as a Class II recall, indicating a situation where the probability of serious adverse health effects is remote. Kenvue directed consumers with the affected lot numbers to stop using the products and contact the company for a replacement or refund. No injuries were publicly reported in connection with the recall.
Skin Sensitivity and Allergic Reactions: The FDA's MedWatch database contains adverse event reports from consumers reporting contact dermatitis and allergic reactions attributed to Band-Aid adhesive components. These reports reflect individual sensitivities and are not the result of a product recall or regulatory action. Kenvue and its predecessor Johnson & Johnson have historically offered latex-free Band-Aid products and hypoallergenic variants to address known sensitivity concerns.
Kenvue Separation Litigation: Following the Kenvue IPO in 2023, a number of shareholder lawsuits were filed against Johnson & Johnson and Kenvue related to disclosures concerning Johnson & Johnson's talc-related liabilities and the allocation of those liabilities between J&J and Kenvue. These cases involve legal proceedings concerning the structure of the corporate separation and are not product-specific to Band-Aid.
Brands Owned by Kenvue
Band-Aid Ownership: Pros & Cons
Advantages
- +Kenvue's dedicated consumer health focus gives Band-Aid a parent company aligned with its market segment
- +Brand name recognition is strong enough that "Band-Aid" functions as a genericized term in common use
- +Kenvue's distribution infrastructure covers more than 100 countries
- +Band-Aid's over-100-year market history has generated deep retail relationships and shelf placement
- +FDA Class I medical device classification provides a regulatory quality floor for all Band-Aid products
Considerations
- -Kimberly-Clark's acquisition (shareholders approved April 29, 2026) is expected to close in H2 2026, creating near-term ownership transition uncertainty
- -Band-Aid's results are not separately disclosed, limiting external assessment of brand-level performance
- -Private-label adhesive bandages from major retailers compete directly on price in the mass-market segment
- -Johnson & Johnson no longer owns Band-Aid, which removes one element of J&J's consumer brand heritage that some consumers may associate with the product
Frequently Asked Questions About Band-Aid
Sources & Further Reading
Where to Buy
Disclosure: We may earn commission from purchases
Band-Aid on AmazonCompetitors to Band-Aid
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| 3m | USA | 1994 | Mass market | Global | All-ages | |
| Johnson Johnson | USA | 1972 | Mass market | Global | All-ages | |
| Haleon | United Kingdom | 1955 | Mass market | Global | All-ages |
Learn More About Competitors
Nexcare
Owned by 3M Company
3M's consumer first aid and wound care brand, launched in 1994, offering bandages, wound dressings, and medical supplies in over 100 countries.
Neosporin
Owned by Johnson & Johnson
American brand of antibiotic ointment and topical wound care products containing triple antibiotic formula, manufactured and marketed by Johnson & Johnson.
Panadol
Owned by Haleon plc
Brand of pain relief medication containing paracetamol (acetaminophen) used for treating mild to moderate pain and fever, manufactured and marketed globally by Haleon.
Competitive Analysis
Market Positioning: Band-Aid competes with 3 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Kenvue Stock Information
Jobs at Kenvue
Latest News About Band-Aid
Related Articles About Band-Aid
View more articles
How Johnson & Johnson Built Its Portfolio Over 100 Years
From Band-Aids to blockbuster drugs, J&J spent a century building one of healthcare's largest empires. Then it split in two. Now Kenvue is being acquired for $48.7 billion.
Spin-off Alert: The Biggest Brands Breaking Away from Their Parents in 2025-2026
From Kenvue leaving J&J to Kraft Heinz splitting in two, corporate spin-offs are reshaping who owns your favorite brands. Here is every major brand separation you need to know about.
Brand Spin-offs: When Companies Sell Off Their Own Brands
From Kenvue to Kellanova, major corporations are spinning off iconic brands into independent companies. Learn why, how it works, and what it means for consumers.
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Accutane
Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.
Activase
Activase (alteplase) is a prescription thrombolytic medication manufactured by Genentech, a wholly-owned subsidiary of Roche. Used to treat acute ischemic stroke, heart attack, and pulmonary embolism.
Acuvue
Acuvue is the world's leading contact lens brand, owned by Johnson & Johnson Vision Care, a division of Johnson & Johnson. The brand covers daily, weekly, and monthly disposable soft contact lenses sold in more than 100 countries.